Page 1 | Search Results | Blood | American Society of Hematology

1-18 of 18

Sort by

Sort Order Select

Journal Articles

Aldehyde Dehydrogenases Play a Role in Acute Myeloid Leukemia and Have Prognostic and Therapeutic Significance

Maura Gasparetto, MD, Shanshan Pei, PhD, Mohammad Minhajuddin, PhD, Daniel A. Pollyea, MD MS, Vasilis Vasiliou, PhD, R. Keith Humphries, MD PhD, Craig T. Jordan, PhD, Clayton A. Smith, MD FRCPC

Blood (2014) 124 (21): 2238.

https://doi.org/10.1182/blood.V124.21.2238.2238

Published: 2014

Journal Articles

Sequential Azacitidine and High-Dose Lenalidomide for Relapsed and Refractory High-Risk MDS and AML: Interim Analysis of a Phase 2 Study

Daniel A Pollyea, Clayton A. Smith, MD FRCPC, Vu H. Nguyen, MD, Aaron Fullerton, MBS, Derek Schatz, BS, Edward J Bedrick, PhD, Jonathan A Gutman, MD

Blood (2014) 124 (21): 3746.

https://doi.org/10.1182/blood.V124.21.3746.3746

Published: 2014

Journal Articles

ALDH Genes and Reactive Aldehydes Play Important Roles in HSCs and Leukemia and May Be Exploited to Treat AML

Maura Gasparetto, MD, Craig T. Jordan, PhD, Mohammad Minhajuddin, Daniel A Pollyea, MD, MS, Vasilis Vasilou, Philip Reigan, PhD, R. Keith Humphries, MD, PhD, Clayton A. Smith, MD, FRCPC

Blood (2013) 122 (21): 2893.

https://doi.org/10.1182/blood.V122.21.2893.2893

Published: 2013

Journal Articles

A Canadian Blood and Marrow Transplant Group (CBMTG) Randomised Trial Comparing G-CSF Mobilized Peripheral Blood Versus G-CSF Stimulated Bone Marrow In Recipients Of Sibling Allografts For Hematologic Malignancies

Blood (2013) 122 (21): 709.

https://doi.org/10.1182/blood.V122.21.709.709

Published: 2013

Journal Articles

Outcomes for Patients Aged 60 and Over Are Similar to Younger Patients Following Reduced-Intensity Allogeneic Stem Cell Transplant for CLL

Cynthia L. Toze, MD, FRCPC, Chinmay B. Dalal, MD, Thomas J. Nevill, MD, FRCPC, Michael J. Barnett, BMBS, Stephen H. Nantel, MD, FRCPC, Donna L. Forrest, MD, Donna E. Hogge, MD, PhD, Heather J. Sutherland, MD, PhD, FRCPC, Kevin W. Song, MD, Yasser Abou Mourad, MD, Raewyn Broady, MBChB, FRACP, Maryse M. Power, MD, FRCPath, Sujaatha Narayanan, MD, Tanya L. Gillan, PhD, FCCMG, Clayton A. Smith, MD, FRCPC, John D. Shepherd, MD, FRCPC

Blood (2011) 118 (21): 3100.

https://doi.org/10.1182/blood.V118.21.3100.3100

Published: 2011

Journal Articles

Allogeneic Hematopoietic Stem Cell Transplantation for CLL: Eradication of Specific FISH Abnormalities with Relation to Gvhd and Transplant Outcomes.

Cynthia Toze, MD, FRCPC, Chinmay B. Dalal, MD, Tanya L. Gillan, PhD, FCCMG, Thomas J. Nevill, MD, FRCPC, Michael J. Barnett, BMBS, Stephen H. Nantel, MD, FRCPC, Donna E. Hogge, MD, PhD, Donna L. Forrest, MD, Heather Sutherland, MD, PhD, FRCPC, Kevin Song, MD, Raewyn Broady, MBChB, FRACP, Maryse Power, MD, FRCPath, Sujaatha Narayanan, MD, Clayton A. Smith, MD, FRCPC, John Shepherd

Blood (2010) 116 (21): 3465.

https://doi.org/10.1182/blood.V116.21.3465.3465

Published: 2010

Journal Articles

Adult Dual Umbilical Cord Blood Transplantation Using Myeloablative Total Body Irradiation (1350cGy) and Fludarabine Conditioning

Junya Kanda, MD, David A. Rizzieri, MD, Cristina Gasparetto, MD, Gwynn D. Long, MD, John P. Chute, MD, Keith M. Sullivan, MD, Ashley Morris, PharmD, Clayton A. Smith, MD, FRCPC, Donna E. Hogge, MD, PhD, Janet Nitta, Kevin Song, MD, Donna Niedzwiecki, PhD, Nelson J. Chao, MD, Mitchell E. Horwitz, MD

Blood (2010) 116 (21): 3523.

https://doi.org/10.1182/blood.V116.21.3523.3523

Published: 2010

Journal Articles

Higher CD 34 Cell Doses Reduce Non Relapse Mortality (NRM) and Do Not Increase the Incidence of Graft Versus Host Disease (GVHD) Following Unrelated Donor Blood Stem Cell Transplantation (SCT).

Sujaatha Narayanan, MBBS, Michael J. Barnett, BM, Yasser R. Abou Mourad, MD, Donna L. Forrest, MD, Donna E. Hogge, MD, Julye C. Lavoie, MD, Stephen H. Nantel, MD, John D. Shepherd, MD, Kevin W. Song, MD, Heather J. Sutherland, MD, Cynthia L. Toze, MD, Clayton A. Smith, MD, Maryse Power, MD, Thomas J. Nevill, MD

Blood (2007) 110 (11): 5091.

https://doi.org/10.1182/blood.V110.11.5091.5091

Published: 2007

Journal Articles

Stem Cell Transplantation (SCT) Improves Survival in Acute Biphenotypic (ABL) and Acute Undifferentiated Leukemia (AUL): A Single Centre Experience.

Blood (2007) 110 (11): 1093.

https://doi.org/10.1182/blood.V110.11.1093.1093

Published: 2007

Journal Articles

Allogeneic Stem Cell Transplant in First Complete Remission Overcomes the Poor Prognosis Associated with the FLT-3 Internal Tandem Duplication in Acute Myeloid Leukemia.

Maryse M. Power, MRCPI, MRCPath, Giovanna Di Sauro, Angela Brooks-Wilson, Thomas J. Nevill, MD, FRCPC, Julye C. Lavoie, MD, Clayton A. Smith, MD, John D. Shepherd, MD, FRCPC, Cindy L. Toze, MD, FRCPC, MHSc, Heather J. Sutherland, MD, FRCPC, PhD, Michael J. Barnett, MB, FRCPath, Yasser A. Abou Mourad, MD, Kevin W. Song, MD, FRCPC, Donna M. Forrest, MD, FRCPC, Steven H. Nantel, MD, FRCPC, Stanley C. Wong, Anna A. Krasnova, Ryan Brinkman, PhD, Donna E. Hogge, MD, PhD, FRCPC

Blood (2007) 110 (11): 3491.

https://doi.org/10.1182/blood.V110.11.3491.3491

Published: 2007

Journal Articles

Second Solid Cancers after Allogeneic Stem Cell Transplantation: The Vancouver Experience.

Genevieve Gallagher, MD, Donna E. Hogge, MD, Thomas J. Nevill, MD, Stephen H. Nantel, MD, Michael J. Barnett, MD, John D. Shepherd, MD, Heather J. Sutherland, MD, Cynthia L. Toze, MD, Clayton A. Smith, MD, Julye C. Lavoie, MD, Kevin W. Song, MD, Donna L. Forrest, MD

Blood (2005) 106 (11): 1120.

https://doi.org/10.1182/blood.V106.11.1120.1120

Published: 2005

Journal Articles

Long-Term Follow-Up Results of Adults with T-Cell Acute Lymphoblastic Leukemia (T-ALL)-The Vancouver Experience.

Yasser R. Abou Mourad, MD, Stephen H. Nantel, MD, Cynthia L. Toze, MD, Thomas J. Nevill, MD, Michael J. Barnett, BM, Donna L. Forrest, MD, Donna E. Hogge, MD, PhD, Julye C. Lavoie, MD, John D. Shepherd, MD, Heather J. Sutherland, MD, PhD, Clayton A. Smith, MD, Kevin W. Song, MD

Blood (2005) 106 (11): 4578.

https://doi.org/10.1182/blood.V106.11.4578.4578

Published: 2005

Journal Articles

Risk Stratification in Acute Promyelocytic Leukemia Based on Elevated White Cell Count and Reduced Platelet Count Does Not Identify Subsequent Relapses: A Retrospective Review of 60 Patients.

Richard T. Doocey, MBChB, Stephen H. Nantel, MD, Michael J. Barnett, BM, Donna L. Forrest, MD, Donna E. Hogge, MD, PhD, Julye C. Lavoie, MD, Thomas J. Nevill, MD, John D. Shepherd, MD, Kevin W. Song, MD, Heather J. Sutherland, MD, PhD, Cynthia L. Toze, MD, Clayton A. Smith, MD

Blood (2004) 104 (11): 4522.

https://doi.org/10.1182/blood.V104.11.4522.4522

Published: 2004

Journal Articles

Philadelphia-Negative Clonal Hematopoiesis Following Imatinib Therapy in Patients with Chronic Myeloid Leukemia (CML).

Yulia Lin, MD, Helene Bruyere, MD, Douglas E. Horsman, MD, Michael J. Barnett, BM, Donna E. Hogge, MD, PhD, Thomas J. Nevill, MD, Stephen H. Nantel, MD, Heather J. Sutherland, MD, PhD, Cynthia L. Toze, MD, John D. Shepherd, MD, Julye C. Lavoie, MD, Kevin W. Song, MD, Clayton A. Smith, MD, Donna L. Forrest, MD

Blood (2004) 104 (11): 4696.

https://doi.org/10.1182/blood.V104.11.4696.4696

Published: 2004

Journal Articles

Daclizumab Therapy Improves Outcome in Steroid Refractory Acute Graft Versus Host Disease (aGVHD).

Richard T. Doocey, MBChB, Matthew J. Greenwood, BMed, Dawn Warkentin, Kevin W. Song, MD, Alan Le, Janet Nitta, Thomas J. Nevill, MD, Michael J. Barnett, MD, Donna L. Forrest, MD, Donna E. Hogge, MD, PhD, Julye C. Lavoie, MD, Stephen H. Nantel, MD, John D. Shepherd, MD, Heather J. Sutherland, MD, PhD, Cynthia L. Toze, MD, Clayton A. Smith, MD

Blood (2004) 104 (11): 5092.

https://doi.org/10.1182/blood.V104.11.5092.5092

Published: 2004

Journal Articles

Salvage of Primary Refractory Acute Leukemia (AL) with High-Dose Etoposide (VP) and Cyclophosphamide (CY) Followed by Early Stem Cell Transplantation (SCT): An Effective Treatment Strategy for AML but Not for All.

Thomas J. Nevill, MD, Asha Johny, MD, Kevin W. Song, MD, Julye C. Lavoie, MD, Cynthia L. Toze, MD, Michael J. Barnett, BM, Donna E. Hogge, MD, John D. Shepherd, MD, Janet Y. Nita, Alan Le, Heather J. Sutherland, MD, Clayton A. Smith, MD, Donna L. Forrest, MD, Stephen H. Nantel, MD

Blood (2004) 104 (11): 5152.

https://doi.org/10.1182/blood.V104.11.5152.5152

Published: 2004

Journal Articles

Acceptable Outcomes for Patients Receiving Allogeneic Hematopoietic Stem Cell Transplantation (AlloSCT) for Relapsed Aggressive Non-Hodgkin’s Lymphoma (NHL).

Richard T. Doocey, MBChB, Kevin W. Song, MD, Cynthia L. Toze, MD, Joseph M. Connors, MD, Thomas J. Nevill, MD, Randy D. Gascoyne, MD, Michael J. Barnett, BM, Donna L. Forrest, MD, Donna E. Hogge, MD, PhD, Julye C. Lavoie, MD, Stephen H. Nantel, MD, John D. Shepherd, MD, Heather J. Sutherland, MD, PhD, Nicholas Voss, MD, Clayton A. Smith, MD

Blood (2004) 104 (11): 3325.

https://doi.org/10.1182/blood.V104.11.3325.3325

Published: 2004

Journal Articles

Hematopoietic Stem Cell Transplant (HSCT) as Primary Treatment for T-Cell Lymphobastic Lymphoma (T-LBL) : An Intention to Treat Analysis.

Kevin W. Song, MD, Thomas J. Nevill, MD, Randy D. Gascoyne, MD, Cynthia L. Toze, MD, Michael B. Barnett, MD, Donna L. Forrest, MD, Donna E. Hogge, MD, Julye C. Lavoie, MD, Stephen H. Nantel, MD, John D. Shepherd, MD, Clayton A. Smith, MD, Heather J. Sutherland, MD, Nicholas J. Voss, MD, Joseph M. Connors, MD

Blood (2004) 104 (11): 900.

https://doi.org/10.1182/blood.V104.11.900.900

Published: 2004

NARROW

Aldehyde Dehydrogenases Play a Role in Acute Myeloid Leukemia and Have Prognostic and Therapeutic Significance

Sequential Azacitidine and High-Dose Lenalidomide for Relapsed and Refractory High-Risk MDS and AML: Interim Analysis of a Phase 2 Study

ALDH Genes and Reactive Aldehydes Play Important Roles in HSCs and Leukemia and May Be Exploited to Treat AML

A Canadian Blood and Marrow Transplant Group (CBMTG) Randomised Trial Comparing G-CSF Mobilized Peripheral Blood Versus G-CSF Stimulated Bone Marrow In Recipients Of Sibling Allografts For Hematologic Malignancies

Outcomes for Patients Aged 60 and Over Are Similar to Younger Patients Following Reduced-Intensity Allogeneic Stem Cell Transplant for CLL

Allogeneic Hematopoietic Stem Cell Transplantation for CLL: Eradication of Specific FISH Abnormalities with Relation to Gvhd and Transplant Outcomes.

Adult Dual Umbilical Cord Blood Transplantation Using Myeloablative Total Body Irradiation (1350cGy) and Fludarabine Conditioning

Higher CD 34 Cell Doses Reduce Non Relapse Mortality (NRM) and Do Not Increase the Incidence of Graft Versus Host Disease (GVHD) Following Unrelated Donor Blood Stem Cell Transplantation (SCT).

Stem Cell Transplantation (SCT) Improves Survival in Acute Biphenotypic (ABL) and Acute Undifferentiated Leukemia (AUL): A Single Centre Experience.

Allogeneic Stem Cell Transplant in First Complete Remission Overcomes the Poor Prognosis Associated with the FLT-3 Internal Tandem Duplication in Acute Myeloid Leukemia.

Second Solid Cancers after Allogeneic Stem Cell Transplantation: The Vancouver Experience.

Long-Term Follow-Up Results of Adults with T-Cell Acute Lymphoblastic Leukemia (T-ALL)-The Vancouver Experience.

Risk Stratification in Acute Promyelocytic Leukemia Based on Elevated White Cell Count and Reduced Platelet Count Does Not Identify Subsequent Relapses: A Retrospective Review of 60 Patients.

Philadelphia-Negative Clonal Hematopoiesis Following Imatinib Therapy in Patients with Chronic Myeloid Leukemia (CML).

Daclizumab Therapy Improves Outcome in Steroid Refractory Acute Graft Versus Host Disease (aGVHD).

Salvage of Primary Refractory Acute Leukemia (AL) with High-Dose Etoposide (VP) and Cyclophosphamide (CY) Followed by Early Stem Cell Transplantation (SCT): An Effective Treatment Strategy for AML but Not for All.

Acceptable Outcomes for Patients Receiving Allogeneic Hematopoietic Stem Cell Transplantation (AlloSCT) for Relapsed Aggressive Non-Hodgkin’s Lymphoma (NHL).

Hematopoietic Stem Cell Transplant (HSCT) as Primary Treatment for T-Cell Lymphobastic Lymphoma (T-LBL) : An Intention to Treat Analysis.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only